E
Exelixis
Alameda, United States
Founded 1994 NASDAQ: EXEL
About
Oncology company developing transformative cancer treatments
Company Details
- Type
- public
- Employees
- 1400+
- Funding
- Public
Key Products
- Cabometyx
- Cometriq
- Zanzalintinib
Oncology company developing transformative cancer treatments